Skip to content
Stimulants · ICD-10 F15.10

Methamphetamine Addiction in Louisville, KY

Methamphetamine is a powerful stimulant that causes extreme dopamine release, strong psychological dependence, and significant medical and psychiatric harm.

A wooden chair in a warm sunlit room
Overview

What methamphetamine addiction looks like.

Methamphetamine is a powerful stimulant that causes extreme dopamine release, strong psychological dependence, and significant medical and psychiatric harm. Kentucky has seen a sustained rise in meth-related hospitalizations and deaths — often complicated by co-use with opioids. There are no FDA-approved medications for meth addiction, which makes structured behavioral treatment and integrated mental health care the standard of care.

Also known as: meth, crystal meth, methamphetamine, ice.

Signs of use

What patients and families actually notice.

  • Rapid, dramatic weight loss
  • Dental decay ("meth mouth") and skin sores
  • Long waking periods (days) followed by extended sleep
  • Hyperactivity, rapid speech, hyperfocus on repetitive tasks
  • Paranoia, hallucinations, or psychosis
  • Severe mood swings and aggression
  • Deteriorating work, school, and family functioning
  • Using despite escalating medical, legal, or psychiatric consequences
Withdrawal timeline

What withdrawal tends to look like.

Every person's experience varies. The windows below describe typical clinical patterns — your plan will be adjusted based on how you respond.

24–72 hours

  • — Crash: severe fatigue
  • — hypersomnia
  • — depression
  • — increased appetite

Days 3–10

  • — Intense dysphoria
  • — anhedonia
  • — strong cravings
  • — cognitive dulling
  • — irritability

Weeks 2–4

  • — Mood and sleep gradually improve
  • — cravings remain strong
  • — anxiety and depression may persist

Weeks 4–12+

  • — Post-acute withdrawal: mood lability
  • — attention problems
  • — anhedonia — extended relapse-risk window
Treatment approach

How we will treat methamphetamine addiction.

Withdrawal management, before admission

While meth withdrawal is not typically life-threatening, medical monitoring supports safety in patients with psychiatric symptoms, cardiac complications, or polysubstance use. Withdrawal management is completed before admission to Golden Grove.

Residential treatment

Structured residential care gives patients protected time during the acute post-use psychiatric window and supports early skill-building.

Contingency management

Contingency management (CM) is a recognized behavioral treatment for stimulant use disorder, and will be part of Golden Grove's behavioral programming. Ask admissions how it works.

Cognitive Behavioral Therapy

CBT addresses relapse triggers, thought patterns, and skill deficits that drive return-to-use.

Integrated mental health care

Meth use frequently produces or worsens anxiety, depression, and psychotic symptoms; integrated psychiatric and substance use disorder (SUD) care is essential.

In Kentucky

The local picture.

Kentucky continues to see rising methamphetamine-related deaths, with meth increasingly involved in polysubstance overdoses alongside fentanyl. Louisville has fewer treatment beds than it needs.

Kentucky Medicaid coverage

Methamphetamine Addiction is typically covered.

Kentucky Medicaid plans typically cover medical detox and residential treatment for stimulant use disorder. There are no FDA-approved medications specifically for meth addiction, but behavioral treatment and integrated mental health care for co-occurring conditions are covered.

Coverage is determined by medical necessity using the American Society of Addiction Medicine (ASAM) criteria. Our admissions team verifies your specific plan on the call.

Frequently asked

Common questions.

Is meth withdrawal dangerous?

Meth withdrawal is usually not life-threatening in the way alcohol or benzodiazepine withdrawal can be, but it produces severe depression and suicidal ideation in some patients. Medical and psychiatric monitoring is strongly recommended. If you're thinking about suicide or self-harm, call or text 988. If you're in immediate danger, call 911.

Is there a medication for meth addiction?

No medication is FDA-approved for stimulant use disorder. Evidence-based behavioral treatments — particularly contingency management and CBT — are the standard of care, along with treatment of any co-occurring psychiatric conditions.

Does Kentucky Medicaid cover meth rehab?

Yes. Kentucky Medicaid plans cover medical detox and residential treatment for stimulant use disorder based on medical-necessity determinations.

Take the next step

Discuss methamphetamine addiction with our admissions team.

Admissions answers 24/7. Golden Grove will accept Kentucky Medicaid. Coverage check happens on the call.